News: Law Enforcement Updates





October 5, 2026: Two charged in connection with fake Ozempic that spurred FDA public alert

Partnership for Safe Medicines

According to court documents, from at least July 2023 to April 2024, the men allegedly obtained the counterfeit products, which included the packaging, pen labels, and needles, from unauthorized sources in China.

Read more...

U.S. sentencing memo for Jennifer Stechkober, USA v Matthew J Kawa, et al., July 2026

Partnership for Safe Medicines

United States District Court Northern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Jennifer Stechkober   Filed July 2026 Read the document.

Read more...

U.S. sentencing memo for Matthew Kawa, USA v Matthew J Kawa, et al., July 2026

Partnership for Safe Medicines

United States District Court Northern District of Indiana USA v Matthew Kawa, et al U.S. sentencing memo, Matthew Kawa Filed July 2026 Read the document.

Read more...

Jennifer Stechkober’s judgment, USA v Matthew J Kawa, et al., July 2026

Partnership for Safe Medicines

United States District Court Northern District of Indiana USA v Matthew Kawa, et al Judgment, Jennifer Stechkober Filed July 2026 Read the document.

Read more...

Matthew Kawa’s judgment, USA v Matthew J Kawa, et al., July 2026

Partnership for Safe Medicines

United States District Court Northern District of Indiana USA v Matthew Kawa, et al Judgment, Matthew Kawa Filed July 2026 Read the document.

Read more...

Plea Agreement for Jennifer Stechkober, USA v Matthew J Kawa, et al., October 2025

Partnership for Safe Medicines

United States District Court Northern District of Indiana USA v Matthew Kawa, et al Plea agreement, Jennifer Stechkober   Filed October 2025 Read the document.

Read more...

Information, USA v Matthew J Kawa, et al., October 2025

Partnership for Safe Medicines

United States District Court Northern District of Indiana USA v Matthew Kawa, et al Information Filed October 2025 Read the document.

Read more...

September 28, 2026: FDA warns compounding pharmacy for producing “inordinate amounts” of weight loss drugs for identical prescriptions

Partnership for Safe Medicines

The Texas-based 503A compounding facility was warned for continuing to manufacture large amounts of weight loss drugs that are "essentially copies" of brand-name products, which is no longer permitted now that shortages have resolved.

Read more...

Notice of Corporate Victims, USA v Swapnadip Roy and Vicky Ramancha, September 2026

Partnership for Safe Medicines

United States District Court Middle District of Florida USA v Swapnadip Roy and Vicky Ramancha Notice of Corporate Victims Filed September 2026 Read the document.

Read more...

Indictment, USA v Swapnadip Roy and Vicky Ramancha, September 2025

Partnership for Safe Medicines

United States District Court Middle District of Florida USA v Swapnadip Roy and Vicky Ramancha Indictment Filed September 2025 Read the document.

Read more...

For all media and general inquiries write us on:

An international law enforcement collaboration protecting the world's medicines.